Comparative in-vitro activity of rufloxacin with five other antimicrobial agents against bacterial enteric pathogens.
Soriano
F
F
Department of Medical Microbiology, Fundación Jiménez Díaz, Madrid, Spain.
Fernández-Roblas
R
R
López
J C
JC
García-Corbeira
P
P
Aguilar
L
L
D000667:Ampicillin / Q000494:pharmacology*; D000890:Anti-Infective Agents / Q000494:pharmacology*; D016123:Campylobacter jejuni / Q000187:drug effects*; D003091:Colistin / Q000494:pharmacology*; D004064:Digestive System / Q000382:microbiology*; D004318:Doxycycline / Q000494:pharmacology*; D004755:Enterobacteriaceae / Q000187:drug effects*; D004926:Escherichia coli / Q000187:drug effects; D024841:Fluoroquinolones; D006801:Humans; D008826:Microbial Sensitivity Tests; D009643:Norfloxacin / Q000494:pharmacology*; D015363:Quinolones / Q000494:pharmacology*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000494:pharmacology*; D014737:Vibrionaceae / Q000187:drug effects*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D000667:Ampicillin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D009643:Norfloxacin; D004318:Doxycycline; C060328:rufloxacin; D003091:Colistin